Publication | Closed Access

Low dose Gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens

Relapsed Breast CancerMedicinePharmacologyBreast CancerPharmacotherapyTaxane-anthracycline-containing RegimensAnti-cancer AgentCancer TreatmentOncologyCancer ChemotherapyWeekly-based Regimen